Prudential Financial’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.66M Buy
29,638
+2,623
+10% +$698K 0.01% 739
2025
Q4
$6.66M Buy
27,015
+1,519
+6% +$320K 0.01% 795
2025
Q3
$4.5M Sell
25,496
-655
-3% -$98K 0.01% 995
2025
Q2
$4.42M Sell
26,151
-1,160
-4% -$170K 0.01% 980
2025
Q1
$4.92M Sell
27,311
-13,882
-34% -$2.34M 0.01% 848
2024
Q4
$6.82M Buy
41,193
+3,254
+9% +$577K 0.01% 754
2024
Q3
$6.91M Sell
37,939
-8,599
-18% -$1.66M 0.01% 837
2024
Q2
$8.55M Buy
46,538
+8,693
+23% +$1.46M 0.01% 706
2024
Q1
$6.73M Sell
37,845
-1,711
-4% -$238K 0.01% 814
2023
Q4
$4.91M Sell
39,556
-30
-0.1% -$3.33K 0.01% 942
2023
Q3
$4.66M Buy
39,586
+29,895
+308% +$3.65M 0.01% 920
2023
Q2
$1.14M Buy
+9,691
New +$989K ﹤0.01% 1747
2023
Q1
Sell
-5,096
Closed -$404K 2638
2022
Q4
$404K Sell
5,096
-2,795
-35% -$207K ﹤0.01% 2120
2022
Q3
$550K Sell
7,891
-3,050
-28% -$220K ﹤0.01% 2032
2022
Q2
$718K Sell
10,941
-9,950
-48% -$619K ﹤0.01% 1952
2022
Q1
$1.39M Buy
+20,891
New +$1.3M ﹤0.01% 1717

Other funds holding KRYS